Chairman Zhang Lieyun increased his stake in HUNLICAR GROUP (03638) by 5,000 shares at a price of HK$7.47 per share.
On July 30th, Chairman Zhang Lieyun increased his holdings in Henry Group (03638) by 5,000 shares, at a price of HKD 7.47 per share, totaling approximately HKD 37,400.
The latest data from the Hong Kong Stock Exchange shows that on July 30, Chairman Zhang Liyun increased his holdings in HUNLICAR GROUP (03638) by 5,000 shares at a price of HK$7.47 per share, for a total amount of approximately HK$37,400. After the increase, the latest number of shares held is 43,415,000, with the latest shareholding ratio at 56.42%.
Related Articles
CANBRIDGE-B(01228): Richard Arthur Moscicki has been appointed as an independent non-executive director.
US Stock Market Move | Biotech company Attovia Therapeutics (ATTO.US) debuted on NASDAQ, with its share price rising 28.82% on the first day of trading.
LEADS BIOLABS-B(09887): The phase II study of Weixin for the treatment of hepatocellular carcinoma has successfully entered the expansion stage.
CANBRIDGE-B(01228): Richard Arthur Moscicki has been appointed as an independent non-executive director.
US Stock Market Move | Biotech company Attovia Therapeutics (ATTO.US) debuted on NASDAQ, with its share price rising 28.82% on the first day of trading.
LEADS BIOLABS-B(09887): The phase II study of Weixin for the treatment of hepatocellular carcinoma has successfully entered the expansion stage.
RECOMMEND
